Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)

Hangzhou Alltest Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,848	1,067	920.38	1,318	1,982	2,179
Trading Asset Securities	276.19	1,325	1,657	1,471	1,833	780.2
Cash & Short-Term Investments	2,124	2,392	2,578	2,789	3,815	2,960
Cash Growth	-13.70%	-7.20%	-7.57%	-26.89%	28.90%	322.40%
Accounts Receivable	145.12	159.05	125.12	100.87	138.66	208.2
Other Receivables	8.68	5.98	6.67	8.18	10.35	67.4
Receivables	153.8	165.03	131.79	109.05	149.02	275.6
Inventory	192.49	176.69	160.32	188.59	193.66	383.84
Prepaid Expenses	-	1.35	0.71	11.65	2.15	8.19
Other Current Assets	97.23	96.54	94.75	63.24	29.63	41.03
Total Current Assets	2,568	2,832	2,965	3,161	4,189	3,668
Property, Plant & Equipment	1,017	1,018	903.44	759.8	317.14	223.62
Long-Term Investments	141.15	145.05	128.67	22.95	12.2	54.32
Other Intangible Assets	133.92	136.82	104.97	110.43	93.03	28.12
Long-Term Deferred Tax Assets	21.78	22.05	22.2	30.18	46.44	3.82
Long-Term Deferred Charges	19.24	16.49	10.35	15.72	17.88	5.66
Other Long-Term Assets	96.92	72.58	51.1	15.53	18.96	24.62
Total Assets	3,997	4,242	4,186	4,116	4,695	4,008

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	82.3	120.05	104.8	77.61	171.17	360.65
Accrued Expenses	16.56	31.68	32.41	33.16	73.51	44.61
Current Portion of Leases	-	0.54	2.34	16.26	8.32	20.06
Current Income Taxes Payable	74.21	76.3	86.43	73.96	73.26	61.71
Current Unearned Revenue	39.25	35.02	40.84	41.62	147.2	226.27
Other Current Liabilities	16.15	23.04	32.37	31.56	37.29	0.91
Total Current Liabilities	229.34	286.64	299.19	274.16	510.75	714.2
Long-Term Leases	6.16	6.87	1.76	7.66	13.44	17.3
Long-Term Unearned Revenue	1.71	2.57	1.64	2.68	-	-
Long-Term Deferred Tax Liabilities	-	-	0.01	-	-	3.2
Total Liabilities	237.22	296.09	302.6	284.5	524.2	734.71

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	79.28	79.28	79.28	79.28	53.9	53.9
Additional Paid-In Capital	1,685	1,680	1,708	1,713	1,744	1,733
Retained Earnings	2,176	2,202	2,177	2,107	2,455	1,487
Treasury Stock	-212.42	-47.41	-113.01	-103.4	-115.56	-
Comprehensive Income & Other	32.56	32.17	32.5	30.75	28.39	0.26
Total Common Equity	3,761	3,947	3,884	3,827	4,166	3,274
Minority Interest	-0.58	-0.35	-0.22	4.31	4.4	-
Shareholders' Equity	3,760	3,946	3,883	3,832	4,171	3,274
Total Liabilities & Equity	3,997	4,242	4,186	4,116	4,695	4,008

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	7.03	7.41	4.1	23.91	21.77	37.36
Net Cash (Debt)	2,117	2,385	2,574	2,765	3,793	2,922
Net Cash Growth	-13.88%	-7.34%	-6.92%	-27.10%	29.80%	317.07%
Net Cash Per Share	26.66	30.11	32.50	34.91	47.86	39.07
Filing Date Shares Outstanding	78.08	77.38	77.87	77.53	78.24	79.78
Total Common Shares Outstanding	78.08	78.69	77.87	78.16	78.24	79.78
Working Capital	2,338	2,545	2,666	2,887	3,678	2,954
Book Value Per Share	48.17	50.16	49.87	48.97	53.25	41.03
Tangible Book Value	3,627	3,810	3,779	3,717	4,073	3,246
Tangible Book Value Per Share	46.45	48.42	48.53	47.56	52.06	40.68
Buildings	-	986.16	403.78	194.44	198.85	58.13
Machinery	-	126.29	117.42	113.61	91.69	58.93
Construction In Progress	-	15.34	459.92	488.25	42.3	82.37

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 14, 2026

Data Sources Report a data error